Apyx Medical Corp (APYX) stock
APYXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3031% above fair value
$2.65−0.16 (-5.69%)
Close on Nov 16, 2026Market cap $111.63MP/E –Yield –
Apyx Medical operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Apyx Medical's operating income for the twelve months ending Sep 30, 2026 was -$3.28M. For fiscal 2025 it was -$6.45M. The highest annual figure on record is $1.05M in fiscal 2012.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$6.45M | – |
| FY2024 | Dec 31, 2024 | -$18.85M | – |
| FY2023 | Dec 31, 2023 | -$17.26M | – |
| FY2022 | Dec 31, 2022 | -$23.56M | – |
| FY2021 | Dec 31, 2021 | -$14.45M | – |
| FY2020 | Dec 31, 2020 | -$20.08M | – |
| FY2019 | Dec 31, 2019 | -$20.87M | – |
| FY2018 | Dec 31, 2018 | -$14.28M | – |
| FY2017 | Dec 31, 2017 | -$13.89M | – |
| FY2016 | Dec 31, 2016 | -$11.39M | – |
| FY2015 | Dec 31, 2015 | -$6.99M | – |
| FY2014 | Dec 31, 2014 | -$5.85M | – |
| FY2013 | Dec 31, 2013 | -$3.67M | -450.5% |
| FY2012 | Dec 31, 2012 | $1.05M | – |
| FY2011 | Dec 31, 2011 | -$18.00K | – |
| FY2010 | Dec 31, 2010 | -$2.75M | -484.9% |
| FY2009 | Dec 31, 2009 | $715.00K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$571.00K | – |
| Q2 FY2026 | Jun 30, 2026 | -$1.81M | – |
| Q1 FY2026 | Mar 31, 2026 | -$911.00K | – |
| Q4 FY2025 | Dec 31, 2025 | $11.00K | – |
| Q3 FY2025 | Sep 30, 2025 | -$832.00K | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.57M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.05M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.05M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.64M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.55M | – |
| Q1 FY2024 | Mar 31, 2024 | -$6.62M | – |
| Q4 FY2023 | Dec 31, 2023 | -$5.78M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.64M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.24M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.61M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.93M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.78M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.98M | – |
| Q1 FY2022 | Mar 31, 2022 | -$5.87M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.69M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.97M | – |
| Q2 FY2021 | Jun 30, 2021 | -$4.04M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.75M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.05M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.37M | – |
| Q2 FY2020 | Jun 30, 2020 | -$6.17M | – |
| Q1 FY2020 | Mar 31, 2020 | -$7.49M | – |
| Q4 FY2019 | Dec 31, 2019 | -$5.96M | – |
| Q3 FY2019 | Sep 30, 2019 | -$4.76M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.42M | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.73M | – |
| Q4 FY2018 | Dec 31, 2018 | -$5.84M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.79M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.93M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.72M | – |
| Q4 FY2017 | Dec 31, 2017 | -$3.24M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.83M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.31M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.74M | – |
| Q4 FY2016 | Dec 31, 2016 | -$8.64M | – |
See a number that looks wrong?